Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #1,251 to #1,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. P-32 → Kel-Tec P-32
  2. Shibasaburo Kitasato → Kitasato Shibasaburo
  3. Kosher → Kosher foods
  4. KAT II → Kuopio Angiogenesis Trial
  5. Azure → Lapis lazuli
  6. Laplace’s Law → Laplace’s law
  7. LACI → Laser Angioplasty For Critical Ischemia
  8. LATE → Late Assessment Of Thrombolytic Efficacy Study
  9. BASKET LATE → Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
  10. LASMA → Late aquired stent malapposition
  11. Lateral cutaneous branches of torso → Lateral abdominal cutaneous branch of intercostal nerve
  12. Leopold Ruzicka → Lavoslav Ružička
  13. Lazar Edeleanu → Lazăr Edeleanu
  14. Guardianship → Legal guardian
  15. Guardian ad litem → Legal guardian
  16. Lehmann-Scheffé theorem → Lehmann–Scheffé theorem
  17. Lemon oil → Lemon
  18. Lemon Balm → Lemon balm
  19. LISA → Lescol In Severe Atherosclerosis Trial
  20. LIPS → Lescol Intervention Prevention Study
  21. LIDO → Levosimendan Infusion Versus Dobutamine
  22. Jaffe-Lichtenstein-Sutro syndrome → Lichtenstein syndrome
  23. LHT → Lifestyle Heart Trial
  24. Light-chain nephropathy → Light chain disease
  25. Light source → Light sources
  26. LIMB → Limbs International Medical Buflomedil Trial
  27. LIMIT AMI → Limitation Of Myocardial Infarction Following Thrombolysis In Acute
  28. LEADERS → Limus Eluted From A Durable Vs Erodable Stent Coating
  29. Lips → Lip (disambiguation)
  30. L-CAD → Lipid-Coronary Artery Disease (Pravastatin)
  31. SLIP → Lipid Profile During Antihypertensive Treatment
  32. LRC-CPPT → Lipid Research Clinics Coronary Primary Prevention Trial
  33. Ddx:Lipoprotein (a) → Lipoprotein (a)
  34. Hyperlipidemia case study one → Lipoprotein disorders case study one
  35. Hyperlipidemia cost-effectiveness of therapy → Lipoprotein disorders cost-effectiveness of therapy
  36. Hyperlipidemia differential diagnosis → Lipoprotein disorders differential diagnosis
  37. Hyperlipidemia epidemiology and demographics → Lipoprotein disorders epidemiology and demographics
  38. Hyperlipidemia future or investigational therapies → Lipoprotein disorders future or investigational therapies
  39. Hyperlipidemia history and symptoms → Lipoprotein disorders history and symptoms
  40. Hyperlipidemia laboratory findings → Lipoprotein disorders laboratory findings
  41. Hyperlipidemia medical therapy → Lipoprotein disorders medical therapy
  42. Hyperlipidemia natural history, complications and prognosis → Lipoprotein disorders natural history, complications and prognosis
  43. Hyperlipidemia pathophysiology → Lipoprotein disorders pathophysiology
  44. Genetics of lipoprotein disorders → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  45. Genetics of primary lipoprotein disorders → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  46. Lipoprotein disorders genetics → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  47. Dyslipidemia genetics → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  48. Genes in hyperlipidemia → Lipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  49. Hyperlipidemia physical examination → Lipoprotein disorders physical examination
  50. Hyperlipidemia risk factors → Lipoprotein disorders risk factors

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"